Smruthi Organics Ltd

Smruthi Organics Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 06 March 2026. However, the analysis and financial metrics discussed below reflect the stock's current position as of 31 March 2026, providing investors with the most up-to-date perspective on the company’s performance and outlook.

For the second consecutive session, Smruthi Organics Ltd has seen its share price decline, hitting a fresh 52-week low of Rs 102 on 30 Mar 2026. This latest drop extends the stock’s recent underperformance despite some positive financial indicators.

Smruthi Organics Ltd is rated Sell by MarketsMOJO, with this rating last updated on 06 Mar 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 20 March 2026, providing investors with the latest insights into the company’s performance and outlook.

Smruthi Organics Ltd has seen its investment rating downgraded from Hold to Sell as of 6 March 2026, reflecting a shift in technical indicators and concerns over its long-term financial growth. Despite some positive quarterly results and attractive valuation metrics, the company’s overall performance and technical trends have prompted a cautious stance among investors.

Smruthi Organics Ltd, a player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating upgraded from Sell to Hold as of 4 March 2026. This change reflects a nuanced improvement across technical indicators, valuation metrics, financial trends, and overall quality assessments, signalling a cautious but positive outlook for investors.

Smruthi Organics Ltd is rated Sell by MarketsMOJO. This rating was last updated on 06 February 2026, reflecting a change from the previous Hold rating. However, all fundamentals, returns, and financial metrics discussed here are current as of 03 March 2026, providing investors with the latest assessment of the stock’s position.

Smruthi Organics Ltd is rated Sell by MarketsMOJO, with this rating last updated on 06 February 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 20 February 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

Smruthi Organics Ltd has witnessed a notable shift in its valuation parameters, moving from a very attractive to an attractive rating, reflecting a nuanced change in price appeal within the Pharmaceuticals & Biotechnology sector. Despite recent downward price pressure, the company’s valuation metrics relative to peers and historical averages suggest a recalibration that investors should carefully analyse.

Smruthi Organics Ltd., a micro-cap pharmaceuticals and biotechnology company with a market capitalisation of ₹137.00 crores, reported a challenging third quarter for FY2026, with net profit declining 32.04% quarter-on-quarter to ₹1.40 crores from ₹2.06 crores in Q2 FY26. On a year-on-year basis, the company managed a modest 5.41% decline from ₹1.48 crores in Q3 FY25. The stock traded at ₹117.00 on February 13, 2026, down 0.85% from the previous close, reflecting investor concerns over the sequential revenue contraction that has pressured profitability.

Smruthi Organics Ltd, a player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Hold to Sell as of 6 February 2026. This revision reflects a combination of deteriorating technical indicators, subdued long-term financial trends, and valuation concerns despite some recent positive quarterly performance.

Smruthi Organics Ltd has seen its investment rating upgraded from Sell to Hold as of 1 February 2026, reflecting a nuanced improvement across technical indicators, valuation metrics, financial trends, and overall quality. This recalibration comes amid a backdrop of mixed long-term performance but recent positive financial results and a shift in technical momentum, prompting a reassessment of the stock’s outlook within the Pharmaceuticals & Biotechnology sector.

Smruthi Organics Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 06 Jan 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 28 January 2026, providing investors with an up-to-date perspective on its performance and outlook.

Smruthi Organics Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has recently formed a Death Cross, a significant technical indicator where the 50-day moving average crosses below the 200-day moving average. This development signals a potential shift towards a bearish trend, reflecting deteriorating momentum and raising concerns about the stock’s long-term strength.

Smruthi Organics Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 17 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 05 January 2026, providing investors with the latest insights into its performance and outlook.

Smruthi Organics Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 17 Nov 2025. However, the analysis and financial metrics discussed here reflect the company’s current position as of 25 December 2025, providing investors with the latest insights into its performance and outlook.

Smruthi Organic, a microcap player in the Pharmaceuticals & Biotechnology sector, has experienced a revision in its market evaluation metrics, reflecting a nuanced shift in its financial and technical outlook. This adjustment follows a detailed reassessment of the company’s quality, valuation, financial trends, and technical indicators, providing investors with a clearer perspective on its current standing.